| Abstrakt: |
This book, with nine chapters and 15 contributing authors, for the most part accomplishes its aim of giving "informed comment in areas where there have been developments, controversy, or where the geriatrician may not be an expert, but where correct management and treatment [are] essential." With so many authors, one could expect some variability in readability and in quality, but in both it is kept to a minimum. The names of drugs will not always be familiar to the American reader, since the trade names of British drugs are often different. To the reader thoroughly familiar with generic names of drugs, this will not present a great problem. However, not all drugs mentioned are available or are commonly known in this country.The first chapter presents an excellent discussion of the complex variables that have impact on the clinical pharmacologic problems of the aged. The following two chapters, while difficult |
